Ravi Parikh, MD, MPP, FACP, of Emory University and the Editor-in-Chief of ASCO AI in Oncology, spoke with So Hee Ahn, BS, MS, of Perelman School of Medicine, University of Pennsylvania, during the 2026 ASCO Quality Care Symposium about her poster presentation on a prospective cohort study of a neurosymbolic AI-augmented prescreening workflow for a national phase III trial of patients with prostate cancer. She explained how the neurosymbolic model differed from other models and how it improved the diversity of patients who were considered eligible for the clinical trial.